Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 1 diabetes
Biotech
Roche drops lupus TCE, retains autoimmune cell therapy interest
The company’s head of pharma told Fierce that Roche still has a strategy for developing cell therapies for autoimmune diseases.
James Waldron
Jul 23, 2026 4:51am
Medtronic debuts Abbott Instinct CGM as MiniMed 780G enters T2D
Sep 2, 2025 11:00am
Vertex diabetes islet cell therapy improves blood sugar levels
Jun 23, 2025 4:21am
Tandem to link pump with Abbott's upcoming glucose-ketone sensor
Jun 11, 2025 10:31am
Senseonics to link 365-day CGM to Sequel’s upcoming insulin pump
Apr 29, 2025 11:30am
Vertex drops cell-device diabetes combo over poor ph. 1 results
Mar 31, 2025 4:20am
